Manitoba Tumour Bank, Canada

Certification Status: Approved
Registration Status: Completed

Objective: THE MTB was established in 1993 as a Breast Tumour Bank, and in 2006 expanded to include collections in Chronic Lymphocytic Leukemia and other leukemias, lung cancer and Head & Neck Cancers. Recently the MTB has begun collections in ovarian cancer and prostate cancer. The MTB aims to provide a high quality research resource to support the mandate of the Research Institute in Oncology and Hematology (a joint institute of the Cancercare Manitoba and the University of Manitoba to improve the outcomes of patients and populations at risk of cancer and blood disorders in Manitoba, Canada and the World.

Registered Biobank Name Manitoba Tumour Bank (MTB)
Biobank Leader Leigh Murphy
Country Canada
Email for biobank inquiries
Principal Investigator Leigh Murphy
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: